359 related articles for article (PubMed ID: 17852158)
1. Multivitamins and phospholipids complex protects the hepatic cells from androgenic-anabolic-steroids-induced toxicity.
Pagonis TA; Koukoulis GN; Hadjichristodoulou CS; Toli PN; Angelopoulos NV
Clin Toxicol (Phila); 2008 Jan; 46(1):57-66. PubMed ID: 17852158
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
[TBL] [Abstract][Full Text] [Related]
3. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal.
Hartgens F; Kuipers H; Wijnen JA; Keizer HA
Int J Sports Med; 1996 Aug; 17(6):429-33. PubMed ID: 8884417
[TBL] [Abstract][Full Text] [Related]
4. Effects of androgenic-anabolic steroids in athletes.
Hartgens F; Kuipers H
Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
[TBL] [Abstract][Full Text] [Related]
5. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
Nieschlag E; Vorona E
Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping.
Solimini R; Rotolo MC; Mastrobattista L; Mortali C; Minutillo A; Pichini S; Pacifici R; Palmi I
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):7-16. PubMed ID: 28379599
[TBL] [Abstract][Full Text] [Related]
7. Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young Men.
Schwingel PA; Cotrim HP; Santos CR; Santos AO; Andrade AR; Carruego MV; Zoppi CC
Subst Use Misuse; 2015; 50(11):1490-8. PubMed ID: 26549387
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis.
D'Andrea A; Caso P; Salerno G; Scarafile R; De Corato G; Mita C; Di Salvo G; Severino S; Cuomo S; Liccardo B; Esposito N; Calabrò R
Br J Sports Med; 2007 Mar; 41(3):149-55. PubMed ID: 17178777
[TBL] [Abstract][Full Text] [Related]
9. Anabolic steroid-induced hepatotoxicity: is it overstated?
Dickerman RD; Pertusi RM; Zachariah NY; Dufour DR; McConathy WJ
Clin J Sport Med; 1999 Jan; 9(1):34-9. PubMed ID: 10336050
[TBL] [Abstract][Full Text] [Related]
10. Anabolic androgenic steroid-induced hepatotoxicity.
Bond P; Llewellyn W; Van Mol P
Med Hypotheses; 2016 Aug; 93():150-3. PubMed ID: 27372877
[TBL] [Abstract][Full Text] [Related]
11. Telephone counseling of athletes abusing anabolic-androgenic steroids.
Takahashi M; Tatsugi T; Kohno Y
J Sports Med Phys Fitness; 2007 Sep; 47(3):356-60. PubMed ID: 17641605
[TBL] [Abstract][Full Text] [Related]
12. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
Melnik B; Jansen T; Grabbe S
J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers.
Urhausen A; Torsten A; Wilfried K
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):369-75. PubMed ID: 12711025
[TBL] [Abstract][Full Text] [Related]
14. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
[TBL] [Abstract][Full Text] [Related]
15. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
16. Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.
Schwingel PA; Cotrim HP; Salles BR; Almeida CE; dos Santos CR; Nachef B; Andrade AR; Zoppi CC
Liver Int; 2011 Mar; 31(3):348-53. PubMed ID: 21040407
[TBL] [Abstract][Full Text] [Related]
17. Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes.
Djordjević V; Stanković I; Stipac AV; Putniković B; Nesković AN
Srp Arh Celok Lek; 2012; 140(11-12):711-6. PubMed ID: 23350243
[TBL] [Abstract][Full Text] [Related]
18. [Hepatoprotective effects of silymarin in androgenic-anabolic steroid-induced liver damage].
Radovanović D; Jovanović D; Mihailović D; Ranković G; Stojiljković N; Dimitrov V
Med Pregl; 2003; 56 Suppl 1():79-83. PubMed ID: 15510919
[TBL] [Abstract][Full Text] [Related]
19. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes.
Karila T; Hovatta O; Seppälä T
Int J Sports Med; 2004 May; 25(4):257-63. PubMed ID: 15162244
[TBL] [Abstract][Full Text] [Related]
20. [Anabolic androgenic steroids in amateur sports in the Netherlands].
Woerdeman J; de Hon O; Levi M; de Ronde WP
Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
